EOLS | EvolusNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$7.37
+$0.21 (+2.93%)

Evolus (EOLS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $7.37 vs 50 $7.92 / 200 $6.28
Projection
No cross projected
Test
No active test
Last cross
Golden cross 18 Jun 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $7.35 vs 50 $6.31 / 200 $9.60
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 13 Oct 2025 ยท projected 24 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $7.27 vs 50 $7.46 / 200 $7.38
Projection
Death cross projected in 10 bars
Test
No active test
Last cross
Golden cross 11 May 2026 ยท projected 29 bars out

Cross history

33
crosses on record since 2019
17 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
18 Jun 2026Golden steepdaily21 bars outNot tested
11 May 2026Golden4-hour29 bars outNot tested
7 Jan 2026Death4-hour14 bars outNot tested
16 Dec 2025Golden4-hour10 bars outNot tested
week of 13 Oct 2025Death steepweekly24 bars outNot tested

About EOLS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.